Patients Diagnosed With Scleroderma: Physical Performance and Functionality

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7+
SponsorHacettepe University

About this trial

Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. In light of all this literature, the aim was to evaluate the biopsychosocial characteristics of both pediatric and adult scleroderma patients and to examine their physical performance and functionality.

Additionally, this study aims to identify effective tests that can be used in future research to assess physical performance and functionality in individuals diagnosed with scleroderma.

Eligibility criteria

Qualifiers

Cases diagnosed with scleroderma,

Cases aged 7-18 years will be included.

Disqualifiers

Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies

Cases that are not willing to participate in the study will be excluded.

Having participated in a regular exercise program for the past 3 months

Individuals who are not willing to participate in the study

Trial design

Treatments tested in this trial

  • Questionnaire and functionality application for child and adult scleroderma patients

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators